Biocon's Kiran Mazumdar-Shaw urges Indian pharma to prioritize innovation

·1 views

Biocon founder Kiran Mazumdar-Shaw has called for Indian pharmaceutical companies to shift their focus towards innovation. She made these remarks during a recent public address, as reported by The Economic Times. Shaw emphasized that the industry must move beyond generic drug manufacturing to remain globally competitive. This push for innovation is seen as crucial for the long-term growth and sustainability of India's pharmaceutical sector.

Read the full story at Economic Times

This is an AI-generated summary. ShortSingh links to the original source for the complete article.

Discussion (0)

Union Minister L Murugan resigns, eyes return to Tamil Nadu politics

Union Minister L. Murugan has submitted his resignation to President Droupadi Murmu. His decision is linked to a desire to return to active politics in his home state of Tamil Nadu. The resignation was officially confirmed by sources within the government. This move paves the way for his potential involvement in the state's political arena.

0 comments Read more at Economic Times

BusinessEconomic Times ·

LIC Launches Three New Insurance Plans on October 19

The Life Insurance Corporation of India (LIC) will introduce three new insurance products on October 19. These plans aim to expand the company's portfolio and offer fresh options to policyholders. The announcement was made by LIC's Chairman, Siddhartha Mohanty, at a press conference. The launch is part of LIC's strategy to align with evolving customer needs and market dynamics.

0 comments Read more at Economic Times

BusinessEconomic Times ·

Indian Navy to commission new indigenous warship INS Samarthak

The Indian Navy will commission a new indigenously built warship named INS Samarthak. The commissioning ceremony is scheduled for June 3 in Goa. The vessel is a specialized offshore patrol ship designed for tasks like deep-sea diving support. This addition enhances the Navy's operational capabilities using domestically produced assets.

0 comments Read more at Economic Times

BusinessEconomic Times ·

SEBI orders compensation for IPO allotment irregularities

A woman investor has been awarded financial compensation after irregularities in an IPO allotment process. The case was adjudicated by SEBI, India's market regulator. This decision follows the discovery of a violation in the share allotment procedure for a company's public offering. The ruling underscores SEBI's commitment to protecting investor rights and ensuring market integrity.

0 comments Read more at Economic Times